Olga Hartwig
About
Olga Hartwig is a human and molecular biologist working on in vitro models of the human intestinal barrier. Within the NEW DEAL project, she is investigating the intestinal barrier crossing of nanocarriers for the treatment of inflammatory bowel diseases.
2021
Surfactant-Free Glibenclamide Nanoparticles: Formulation, Characterization and Evaluation of Interactions with Biological Barriers
Arrua E, Hartwig O, Ho D, Loretz B, Murgia X, Salomon C, Lehr C (2021)
Pharmaceutical research 38 (6): 1081-1092DOI: 10.1007/s11095-021-03056-2
2019
Macro- and Microrheological Properties of Mucus Surrogates in Comparison to Native Intestinal and Pulmonary Mucus
Huck B, Hartwig O, Biehl A, Schwarzkopf K, Wagner C, Loretz B, Murgia X, Lehr C (2019)
Biomacromolecules 20 (9): 3504-3512DOI: 10.1021/acs.biomac.9b00780
2018
The role of mucus on drug transport and its potential to affect therapeutic outcomes
Murgia X, Loretz B, Hartwig O, Hittinger M, Lehr C (2018)
Advanced Drug Delivery Reviews 124: 82-97DOI: 10.1016/j.addr.2017.10.009
Oral delivery of macromolecular drugs
Savla R, Hartwig O, Lim Chin W, Loretz B, Lehr C (2018)
Pharm. Technol. Eur. 30 (7): 22-26